financetom
Business
financetom
/
Business
/
Faraday Future Enters UAE Market Through Exclusive Deal
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Faraday Future Enters UAE Market Through Exclusive Deal
Oct 24, 2025 5:44 AM

Faraday Future Intelligent Electric Inc. ( FFAI ) shares are trading higher premarket on Friday after the company disclosed a deal for official entry into the United Arab Emirates (UAE) market.

FFAI shares are trending higher. Find out why here

The company penned a strategic cooperation with RAK Motors, an automotive dealer based in Ras Al Khaimah, one of the emirates in the UAE.

As an experienced automotive distributor representing major global brands like Toyota ( TM ) and Nissan (NASDAQ-SMALL:NSANY) , RAK Motors will serve as Faraday Future’s exclusive agent in the UAE for up to one year.

Also Read: EXCLUSIVE: Faraday Future Wants A Tesla-Style Breakout—And Mariah Carey’s Already Driving

Partnership Details

This partnership authorizes RAK Motors to handle the sales, delivery, and after-sales service for the FX Super One within the UAE region.

These responsibilities include managing displays, test drives, delivery, and providing full customer care, all under the close direction of FF.

This cooperation is a significant milestone for FF, as it establishes a full, end-to-end ecosystem in the UAE for the FX Super One, covering everything from production to service.

FF Executive Vice President and Head of UAE, Tin Mok added,

“The Middle East will serve as a critical springboard for FF and FX’s future expansion into Europe, Africa, and other global markets.”

Recent Key Events

Last week, the company achieved a major production milestone for the FX Super One. It signed the procurement agreement for the first batch of complete parts, and shipment is starting immediately.

Price Action: FFAI shares are up 2.08% at $1.470 premarket at the last check on Friday.

Read Next:

Qualigen Therapeutics (QLGN) Stock Soars 62% After-Hours On Partnership With BitGo To Build Multi-Asset Crypto Treasury

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BioAffinity Raises Nearly $1.8 Million From Offerings
BioAffinity Raises Nearly $1.8 Million From Offerings
Aug 5, 2024
01:50 PM EDT, 08/05/2024 (MT Newswires) -- BioAffinity Technologies ( BIAF ) said Monday it raised a total of under $1.8 million from a registered direct offering, concurrent private placement, and warrant inducement. The company said it issued 1,041,667 shares at $1.25 apiece to three existing accredited investors who exercised outstanding warrants for proceeds of $1.3 million. The investors also...
Fannie Mae, Freddie Mac set to tighten real-estate lending rules, WSJ reports
Fannie Mae, Freddie Mac set to tighten real-estate lending rules, WSJ reports
Aug 5, 2024
(Reuters) - Mortgage financing firms Fannie Mae and Freddie Mac are set to impose stricter rules for commercial property lenders and brokers, following a budding regulatory crackdown on fraud in the multi-trillion dollar market, the Wall Street Journal reported on Monday. Lenders would have to independently verify financial information related to borrowers for apartment complexes and other multifamily properties, the...
Church & Dwight Analysts Slash Their Forecasts After Q2 Results
Church & Dwight Analysts Slash Their Forecasts After Q2 Results
Aug 5, 2024
Church & Dwight Co., Inc ( CHD ). reported upbeat second-quarter adjusted EPS results on Friday. Church & Dwight ( CHD ) reported quarterly earnings of 93 cents per share which beat the analyst consensus estimate of 84 cents per share. The company reported quarterly sales of $1.511 billion which met the analyst consensus estimate, according to data from Benzinga...
Jaguar Health to Detail Regulatory Strategy for Antidiarrheal Drug for Cancer Patients Next Week
Jaguar Health to Detail Regulatory Strategy for Antidiarrheal Drug for Cancer Patients Next Week
Aug 5, 2024
02:06 PM EDT, 08/05/2024 (MT Newswires) -- Jaguar Health ( JAGX ) Monday said it will explore ways to win additional regulatory approvals for its crofelemer antidiarrheal drug in patients with certain types of cancers, but failed to meet the primary endpoint across all tumor types. Crofelemer currently is approved by the US Food and Drug Administration to help control...
Copyright 2023-2026 - www.financetom.com All Rights Reserved